Quick Answer
Co-Diagnostics, Inc. reported Total Assets of $24.74 million for fiscal year 2025.
Co-Diagnostics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $24.74M | -61.1% |
| 2024 | $63.56M | -33.3% |
| 2023 | $95.32M | -22.6% |
| 2022 | $123.09M | -23.1% |
| 2021 | $160.03M | +124.6% |
| 2020 | $71.24M | +3115.7% |
| 2019 | $2.22M | +42.6% |
| 2018 | $1.55M | -66.7% |
| 2017 | $4.66M | +259.8% |
| 2016 | $1.30M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $44.74M | -38.2% | -3.7% |
| June 30, 2025 | $46.47M | -42.4% | -15.7% |
| March 31, 2025 | $55.15M | -36.4% | -13.8% |
| December 31, 2024 | $64.00M | -32.9% | -11.6% |
| September 30, 2024 | $72.38M | -33.4% | -10.3% |
| June 30, 2024 | $80.70M | -28.5% | -6.9% |
| March 31, 2024 | $86.67M | -25.9% | -9.1% |
| December 31, 2023 | $95.32M | -22.6% | -12.3% |
- Co-Diagnostics, Inc. showed a decrease of -61.1% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Co-Diagnostics, Inc.’s total assets has grown by 1809.4% (from $1.30 million to $24.74 million).
- The most recent figure is from Co-Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: